# RETeval Study for Diabetic Retinopathy

> **NCT01950663** · NA · COMPLETED · sponsor: **Inoveon Corporation** · enrollment: 468 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DEVICE:** RETeval

## Key facts

- **NCT ID:** NCT01950663
- **Lead sponsor:** Inoveon Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 468 (ACTUAL)
- **Last updated:** 2017-06-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01950663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01950663, "RETeval Study for Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01950663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*